-->

Company Registry

mAbDx Inc (AKA:mAbDx)
Profile last edited on: 11/10/2017

Novel immunodiagnostics through biomarker discovery and immunoassay development
Year Founded
2011
First SBIR Year
2014
Latest SBIR Award
2021
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1440 Franklin Boulevard
Eugene, OR 97403
   (541) 521-8056
   info@mabdx.com
   www.mabdx.com
Multiple Locations:   
Congressional District:   04
County:   Lane

Public Profile

Founded by someone also involved in start-up of MitoSciences - itself an SBIR involved firm that in 2011 was sold to Abcam PLC - mAbDx specializes in creating novel immunodiagnostics through biomarker discovery and immunoassay development. Focused on development and deployment of immunochemical reagents and immunoassays as tools for basic and clinical research, principals of the firm have been responsible for development of hundreds of monoclonal antibodies (mAbs) used in academic researc, many of these mAbs having been licensed out by the UO for commercialization by leading biotechnology companies. At mAbDx many other research collaborations with academic and clinical partners have been established to develop and validate the utility of new mAbs and assays for basic and clinical research. Many of the mAbs and assays resulting from these collaborations have been commercialized, allowing their use by independent researchers in a wide range of published studies. Internal to mAbDx, work is organized around sveral areas: Systemic Inflammatory Response Syndrome (SIRS): Sepsis (SIRS with documented infection); Marine Shellfish Vibriosis: Head and Neck Squamous Cell Carcinoma (HNSCC) and Inherited Mitochondrial Diseases

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency